STOCK TITAN

RELY (NASDAQ: RELY) executive files to sell 1,430 restricted shares

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

RELY executive filed a Form 144 proposing the sale of 1,430 shares of Common Stock. The filing lists the securities as Restricted Stock Units with an effective date of 08/25/2025. The excerpt also reports recent 10b5-1 sales by Joshua David Hug: 29,049 shares sold on 03/04/2026 for $522,425.93 and 40,777 shares sold on 03/02/2026 for $682,150.28.

Positive

  • None.

Negative

  • None.

Insights

Form 144 notifies the market of a proposed sale of restricted shares by an insider.

Form 144 is a statutory notice under the Securities Act that an affiliate intends to sell restricted or control securities; the filing here lists 1,430 shares tied to restricted stock units with an 08/25/2025 date. The filing also documents recent sales executed under a 10b5-1 plan on 03/02/2026 and 03/04/2026.

Cash‑flow treatment and whether the proposed sale is part of the existing plan are not detailed in the excerpt; subsequent filings or transaction confirmations would show settlement details.

Proposed sale 1,430 shares Restricted Stock Units dated 08/25/2025
10b5-1 sale 29,049 shares Sold 03/04/2026 for $522,425.93
10b5-1 sale 40,777 shares Sold 03/02/2026 for $682,150.28
Form 144 regulatory
"Filer Information | 144: Filer Information"
Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.
Restricted Stock Units financial
"Securities To Be Sold | Restricted Stock Units | Issuer"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
10b5-1 Sales Plan regulatory
"10b5-1 Sales Plan for JOSHUA DAVID HUG"

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the RELY Form 144 filed on 04/06/2026 report?

It reports a proposed sale of 1,430 shares of Common Stock tied to Restricted Stock Units dated 08/25/2025. It also lists two 10b5-1 sales in March 2026 totaling 69,826 shares across two trades.

Who executed recent 10b5-1 sales disclosed in the RELY filing?

The filing shows 10b5-1 sales attributed to Joshua David Hug. Trades: 40,777 shares on 03/02/2026 for $682,150.28 and 29,049 shares on 03/04/2026 for $522,425.93.

Are the shares in the Form 144 sale free trading?

The Form 144 lists the securities as Restricted Stock Units with an 08/25/2025 date, indicating the shares originate from restricted awards. The filing does not state current transferability or settlement mechanics.

Does the Form 144 show who will broker the sale for RELY?

Yes; the excerpt names Morgan Stanley Smith Barney LLC as the broker/planner for the transaction. The filing does not disclose execution timing or whether sales will follow the 10b5-1 plan schedule.